North America Dental Soft-Tissue Regeneration Market (2024-2029)
The North America Dental Soft-Tissue Regeneration Market was valued at $164.1 Million in 2024 and projected to reach to $242.4 Million by 2029, representing a compound annual growth rate of 8.1%. North America's dental soft-tissue regeneration market is positioned for sustained growth through 2029, with the market expanding from $164.1 million to $242.4 million.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Dental Soft-Tissue Regeneration Market Trends and Insights
- In North America, the market is driven by advanced healthcare infrastructure, high patient awareness, and increasing adoption of regenerative dental procedures.
- North America represents a mature market with strong demand for periodontal and implant-related soft-tissue solutions, supported by favorable reimbursement policies and significant investment in dental biotechnology. The North America market benefits from a well-established dental professional base and rising prevalence of periodontal disease across the region.
- In North America, technological innovations in biomaterials and growth factors are accelerating clinical adoption.
- North America's competitive landscape includes both established dental companies and emerging biotech firms focused on soft-tissue regeneration solutions.
- The forecast period through 2029 reflects North America's commitment to advancing regenerative dentistry and improving patient outcomes through evidence-based clinical protocols..
Key Market Statistics
- CAGR (2024-2029) 8.1% CAGR
- Market Size, 2024 ~USD 164.1 Million
- Forecast, 2029 ~USD 242.4 Million
- Geography North America
North America Dental Soft-Tissue Regeneration Market Overview
Market Leadership :
North America commands the largest share of the global dental soft-tissue regeneration market, with the US alone representing $141.39 million in 2024, demonstrating strong clinical adoption and patient demand for advanced periodontal therapies.
Accelerated Growth Trajectory :
The North American market is expanding at 8.1% CAGR, outpacing the global rate of 7.8%, driven by increasing prevalence of periodontal disease, rising cosmetic dentistry demand, and widespread insurance coverage for regenerative procedures.
Advanced Healthcare Infrastructure :
North America's mature dental healthcare ecosystem, characterized by cutting-edge research institutions, FDA-approved regenerative products, and high-quality clinical standards, supports rapid market expansion and innovation in soft-tissue regeneration technologies.
Strong Patient Awareness & Adoption :
High patient education levels, favorable reimbursement policies, and growing preference for minimally invasive regenerative treatments over traditional grafting procedures are accelerating market penetration across North American dental practices.
North America Dental Soft-Tissue Regeneration Market Dynamics
- This growth trajectory reflects increasing investment in periodontal regenerative technologies, rising prevalence of gum disease among aging populations, and expanding clinical applications beyond traditional periodontal therapy.
- The region benefits from robust healthcare infrastructure, strong regulatory frameworks, and significant R&D activities by leading dental companies. Key drivers include growing patient awareness of aesthetic outcomes, increasing adoption of guided tissue regeneration (GTR) and bone morphogenetic protein (BMP) technologies, and expanding insurance coverage for regenerative procedures.
- North America's mature market dynamics, combined with continuous product innovation and clinical evidence supporting efficacy, position the region as a growth engine for the global dental soft-tissue regeneration market through the forecast period..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- North America's dental soft-tissue regeneration market is valued at $164.1 million in 2024 and will reach $242.4 million by 2029, representing an 8.1% CAGR.
- North America leads in adoption of advanced regenerative dental technologies due to high healthcare spending and strong clinical infrastructure.
- In North America, favorable reimbursement policies and rising periodontal disease prevalence are key growth catalysts through 2029.
- North America's market is characterized by intense competition between multinational dental corporations and innovative biotech startups developing next-generation soft-tissue solutions.
Dental Soft-Tissue Regeneration Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | PERIODONTOLOGY (Application) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 7.8% from 2024 to 2029 |
| Largest Segment | AUTOGRAFTS (Product Type) |
| Market Size Base Year (Billions) | ~USD 0.34 (2024) |
| Revenue Forecast (Billions) | ~USD 0.54 (2029) |
| Segments Covered | Product Type, Application, End User |
North America Dental Soft-Tissue Regeneration Market Report Segmentation
3 segment dimensions are covered across the global market.
By Product Type
- Autografts
- Collagen-Based Membranes
- Other Products
- Synthetic Biomaterials
By Application
- Implantology
- Other Applications
- Periodontology
By End User
- Academic & Research Institutes
- Dental Hospitals
- Dsos & Independent Clinics
Target Audience
- Dental Device Manufacturers : Manufacturers of regenerative dental products need North America market intelligence to assess market opportunity, benchmark against competitors, identify unmet clinical needs, and develop targeted product strategies for the world's largest dental soft-tissue regeneration market.
- Dental Practice Groups & Clinicians : Dental practitioners and practice management organizations require market insights to understand treatment adoption trends, patient demand patterns, reimbursement landscape, and competitive offerings to optimize clinical service portfolios and revenue growth.
- Healthcare Investment & Private Equity : Investment firms evaluating dental healthcare opportunities need comprehensive North America market data to assess growth potential, identify acquisition targets, evaluate market valuations, and make informed capital allocation decisions in the regenerative dentistry sector.
- Pharmaceutical & Biotech Companies : Biotech firms developing regenerative therapies and biologics require North America market analysis to understand clinical adoption barriers, competitive positioning, regulatory pathways, and commercial viability for soft-tissue regeneration products.
- Healthcare Consultants & Analysts : Management consultants and market analysts need detailed North America market segmentation and forecasts to support client strategy development, competitive analysis, market entry planning, and investment thesis validation in dental regeneration markets.
Key Companies in the North America Dental Soft-Tissue Regeneration Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HENRY SCHEIN, INC. | United States | Public Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| ENVISTA | United States | Public Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| ZIMVIE INC. | United States | Private Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| DENTSPLY SIRONA INC. | United States | Public Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| ABBVIE INC. | United States | Public Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | United Kingdom | Public Company | Collagen-based Membranes,Synthetic Biomaterials,Autografts, |
| TISSUE REGENIX | United Kingdom | Private Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| MECCELLIS BIOTECH | France | Collagen-based Membranes,Synthetic Biomaterials,Autografts, |
HENRY SCHEIN, INC.
Henry Schein, Inc. is a publicly traded American company founded in 1932 with approximately 25,000 employees. It is a leading global distributor of dental, medical, and veterinary products and services.
ENVISTA
Envista is a publicly traded American company founded in 2018 with approximately 12,000 employees. The company operates as a global provider of dental products, technologies, and services.
ZIMVIE INC.
Zimvie Inc. is a privately held American company founded in 2021 with approximately 1,770 employees. The company focuses on dental implants, bone regeneration, and related surgical solutions.
DENTSPLY SIRONA INC.
Dentsply Sirona Inc. is a publicly traded American company founded in 2015. The company is a leading manufacturer and distributor of dental products, technologies, and equipment.
ABBVIE INC.
AbbVie Inc. is a publicly traded American pharmaceutical company founded in 2012 with approximately 57,000 employees. The company develops and markets a broad range of pharmaceutical products across multiple therapeutic areas.
ADVANCED MEDICAL SOLUTIONS GROUP PLC
Advanced Medical Solutions Group PLC is a publicly traded British company founded in 1991 with approximately 1,800 employees. The company specializes in advanced wound care and surgical solutions.
TISSUE REGENIX
Tissue Regenix is a privately held British company founded in 2006 with approximately 92 employees. The company develops regenerative medicine and advanced wound care products.
MECCELLIS BIOTECH
Meccellis Biotech is a French company founded in 2011 that operates in the biotechnology sector. The company focuses on regenerative medicine and cellular therapy solutions.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 141.39 Million |
| Canada | USD 9.98 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation for North America ($164.1M in 2024) with 8.1% CAGR through 2029, enabling accurate financial forecasting and investment decision-making for dental regeneration product launches and market expansion strategies.
- Competitive Landscape Intelligence : Understand North America's mature market dynamics, identify leading players, assess product positioning, and benchmark competitive strategies specific to US and Canadian dental markets to optimize market entry and growth initiatives.
- Regional Growth Driver Analysis : Gain insights into North America-specific growth catalysts including advanced healthcare infrastructure, high patient awareness, favorable reimbursement policies, and regulatory environment to inform targeted marketing and clinical development strategies.
- Country-Level Market Breakdown : Access granular market data for US ($141.39M) and Canada ($9.98M) to identify high-opportunity segments, allocate resources efficiently, and develop country-specific commercialization strategies aligned with local market dynamics.
- Strategic Planning & Risk Mitigation : Leverage comprehensive North America market analysis to identify emerging trends, assess competitive threats, evaluate market saturation levels, and develop informed go-to-market strategies that minimize investment risk and maximize ROI.
Frequently asked questions
What is the current market size of dental soft-tissue regeneration in North America?
In 2024, North America's dental soft-tissue regeneration market is valued at $164.1 million, with expectations to grow to $242.4 million by 2029.
What is the projected growth rate for North America's dental soft-tissue regeneration market?
North America's market is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2029.
What factors are driving growth in North America's dental soft-tissue regeneration market?
In North America, growth is driven by advanced healthcare infrastructure, high patient awareness, favorable reimbursement policies, rising periodontal disease prevalence, and technological innovations in biomaterials and growth factors.
Who are the key competitors in North America's dental soft-tissue regeneration market?
North America's competitive landscape includes established multinational dental corporations, specialized periodontal companies, and emerging biotech firms developing innovative soft-tissue regeneration solutions.
What products and solutions are included in North America's dental soft-tissue regeneration market?
North America's market encompasses biomaterials, growth factors, guided tissue regeneration membranes, bone grafts, and advanced biologics designed for periodontal and implant-related soft-tissue applications.
RESEARCH METHODOLOGY
This study involved four key activities to estimate the current size of the dental soft-tissue regeneration market. First, extensive secondary research was conducted to gather information about the market, as well as related markets and the overall parent market. Next, the findings, assumptions, and estimates were validated through primary research conducted with industry experts across the value chain. Both top-down and bottom-up approaches were utilized to determine the overall market size. Finally, market breakdown and data triangulation techniques were employed to estimate the sizes of various segments and subsegments.
Secondary Research
The secondary research process utilized a variety of sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company documents, investor presentations, and SEC filings. This method was employed to gather information relevant to a comprehensive, technical, market-focused, and commercial analysis of the dental soft-tissue regeneration market. It also helped obtain crucial details about key players in the industry, market classification, and segmentation based on current trends, extending down to the most granular levels. Additionally, important developments related to market and technological perspectives were captured. A database of key industry leaders was created using the information collected through secondary research.
Primary Research
In the primary research process, a variety of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations operating in the dental soft-tissue regeneration market. On the demand side, primary sources consisted of industry experts, purchasing and sales managers, doctors, and personnel from research organizations. This primary research aimed to validate market segmentation, identify key players, and collect insights on major industry trends and market dynamics.
A breakdown of the primary respondents for the dental soft-tissue regeneration market is provided below:
Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global dental soft-tissue regeneration market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global dental soft-tissue regeneration market was split into various segments and subsegments based on:
- List of major players operating in the products market at the regional and/or country level
- Product mapping of various dental soft-tissue regeneration manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from dental soft-tissue regenerative products (or the nearest reported business unit/product category)
- Revenue mapping of major players to cover at least 70–75% of the global market share as of 2023
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global diagnostics market
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Market Size Estimation (Bottom-up Approach & Top-down Approach)
Data Triangulation
After arriving at the overall size of the global dental soft-tissue regeneration market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Market Definition
Dental soft-tissue regeneration involves restoring or reconstructing soft tissues, including the gums and connective tissues surrounding the teeth. This process seeks to facilitate the healing of tissues lost due to gum disease or trauma to enhance the health and aesthetic appearance of the gums and their functionality. These procedures can be effectively used in the treatment of gum recession, tissue defects around the implants, or any other soft-tissue defects, and eventually, to improve the smile.
Stakeholders
- Dental soft-tissue regenerative material manufacturing companies
- Distributors and suppliers of dental soft-tissue regeneration products
- Medical device companies
- Research and consulting firms
- Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
- Research institutes and academic centers
- Contract research organizations (CROs)
- Government associations
- Venture capitalists and investors
Report Objectives
- To define, describe, and forecast the dental soft-tissue regeneration market based on product type, application, end user, and region
- To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events
- To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall dental soft-tissue regeneration market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To strategically profile key players in the dental soft-tissue regeneration market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall dental soft-tissue regeneration market
- To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
- To analyze the generative AI impact on the dental soft-tissue regeneration market
Get the Full Dental Soft-Tissue Regeneration Market Report
Full forecast, segment splits, and company analysis for all Dental Soft-Tissue Regeneration Market.
- Canada Dental Soft-Tissue Regeneration Market
- US Dental Soft-Tissue Regeneration Market
- Germany Dental Soft-Tissue Regeneration Market
- UK Dental Soft-Tissue Regeneration Market
- France Dental Soft-Tissue Regeneration Market
- Spain Dental Soft-Tissue Regeneration Market
- Italy Dental Soft-Tissue Regeneration Market
- Japan Dental Soft-Tissue Regeneration Market
- China Dental Soft-Tissue Regeneration Market
- India Dental Soft-Tissue Regeneration Market
- Australia Dental Soft-Tissue Regeneration Market
- South Korea Dental Soft-Tissue Regeneration Market
- Brazil Dental Soft-Tissue Regeneration Market
- Mexico Dental Soft-Tissue Regeneration Market
- Argentina Dental Soft-Tissue Regeneration Market
- GCC Countries Dental Soft-Tissue Regeneration Market
- Rest Of Asia Pacific Dental Soft-Tissue Regeneration Market
- Rest Of Europe Dental Soft-Tissue Regeneration Market
- Rest Of Latin America Dental Soft-Tissue Regeneration Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
